4//SEC Filing
Kirk Christopher J. 4
Accession 0001209191-20-007047
CIK 0001645666other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 8:13 PM ET
Size
5.0 KB
Accession
0001209191-20-007047
Insider Transaction Report
Form 4
Kirk Christopher J.
DirectorCEO
Transactions
- Purchase
Common Stock
2020-02-04$2.60/sh+38,461$99,999→ 342,609 total
Footnotes (2)
- [F1]Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.
- [F2]Total reflects 1,214 shares of common stock acquired on November 15, 2019 through the Company's 2018 Employee Stock Purchase Plan.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001744253
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 8:13 PM ET
- Size
- 5.0 KB